Capricor Therapeutics, Inc. (CAPR)
28.51
-0.64
(-2.20%)
USD |
NASDAQ |
Feb 20, 16:00
27.96
-0.55
(-1.93%)
After-Hours: 20:00
Capricor Therapeutics SG&A Expense (Quarterly) : 5.925M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 76.66M |
| Agenus, Inc. | 10.86M |
| Curis, Inc. | 3.653M |
| LadRx Corp. | 0.6909M |
| Plus Therapeutics, Inc. | 3.443M |